Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2025 > Vol 6, №2 (2025) > Analysis of the newborns condition during active management of pregnant women with a high risk of fetal growth restriction development

Analysis of the newborns condition during active management of pregnant women with a high risk of fetal growth restriction development

Nart F. Kuneshko , Anton V. Ershov , Arina V. Lazarchuk

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Aim. To assess the features of pregnancy progression in women with high risk of fetal growth restriction, and to investigate the condition of newborns born to these women.
Material and methods. A prospective non-randomized study including 534 women at high risk of fetal growth restriction. The control group consisted of 112 patients with a physiological pregnancy. The women with high risk of fetal growth restriction were divided into groups based on the timing of seeking medical assistance. Anamnestic data pregnancy course and outcomes, and fetal condition were evaluated.
Results. Early toxicosis, fetal distress, and placental insufficiency were more frequent in the comparison group, where active pregnancy management was not carried out. The frequency of preterm labor was similar between the study and control groups, but in the comparison group, the primary method of delivery was cesarean section. In the groups at high risk of fetal growth restriction, lower birth weight and length of newborns were observed. Fetal growth restriction was diagnosed in 29.96% of the children, more often in the comparison group.
Conclusion. Early intervention and correction of pathology in women with high risk of fetal growth restriction improve pregnancy outcomes and reduce fetal risks.
Keywords: fetal growth restriction, pregnancy management, assessment of newborn condition, placental insufficiency.

About the Author

Nart F. Kuneshko 1 , Anton V. Ershov 2 , Arina V. Lazarchuk 2

1 Odintsovo Regional Hospital, Odintsovo, Russia;

2 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

References

1. Melamed N, Baschat A, Yinon Y et al. FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. Int J Gynaecol Obstet 2021;152(Suppl.1):3-57. DOI: 10.1002/ijgo.13522
2. Malhotra A, Allison BJ, Castillo-Melendez M et al. Neonatal Morbidities of Fetal Growth Restriction: Pathophysiology and Impact. Front Endocrinol (Lausanne) 2019;(10):55. DOI: 10.3389/fendo.2019. 00055
3. Kametas NA, Nzelu D, Nicolaides KH. Chronic hypertension and superimposed preeclampsia: screening and diagnosis. Am J Obstet Gynecol 2022;226(2S):S1182-S1195. DOI: 10.1016/j.ajog.2020.11.029
4. King VJ, Bennet L, Stone PR et al. Fetal growth restriction and stillbirth: Biomarkers for identifying at risk fetuses. Front Physiol 2022;(13):959750. DOI: 10.3389/fphys.2022.959750
5. Стрижаков А.Н., Тимохина Ф.Т., Баев О.Р. Фетоплацентарная недостаточность: патогенез, диагностика и лечение. Вопросы гинекологии, акушерства и перинатологии. 2003;(2):53-63.
Strizhakov A.N., Timokhina F.T., Baev O.R. Fetoplacental insufficiency: pathogenesis, diagnostics and treatment. Issues of gynecology, obstetrics and perinatology. 2003;(2):53-63 (in Russian).
6. Barker DJ, Osmond C, Golding J et al. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989;298(6673):564–7.
7. Tsikouras P, Antsaklis P, Nikolettos K et al. Diagnosis, Prevention, and Management of Fetal Growth Restriction (FGR). J Pers Med 2024;14(7):698. DOI: 10.3390/jpm14070698
8. Bujold E, Roberge S, Lacasse Y et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116(2 Pt 1):402-14. DOI: 10.1097/AOG.0b013e3181e9322a
9. Verlijsdonk JW, Winkens B, Boers K et al. Suspected versus non-suspected small-for-gestational age fetuses at term: perinatal outcomes. J Matern Fetal Neonatal Med 2012;25(7):938-43. DOI: 10.3109/14767058.2011.600793
10. Lindqvist PG, Molin J. Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome? Ultrasound Obstet Gynecol 2005;25(3):258-64. DOI: 10.1002/uog.1806. PMID: 15717289.
11. Milosavljevic J, Pejcic A, Arsenijevic P et al. Factors associated with fetal growth restriction and small for gestational age newborns. Ginekol Pol 2023;94(8):645-53. DOI: 10.5603/GP.a2022.0127. Epub 2022 Nov 30. PMID: 36448354.

Портал CON-MED.RU:
https://con-med.ru/magazines/klinicheskiy_razbor_v_obshchey_meditsine/klinicheskiy_razbor_v_obshchey_meditsine-02-2025/analiz_sostoyaniya_novorozhdennykh_pri_aktivnom_vedenii_beremennykh_s_vysokim_riskom_razvitiya_zader/

For citation:Kuneshko N.F., Ershov A.V., Lazarchuk A.V. Analysis of the newborns condition during active management of pregnant women with a high risk of fetal growth restriction development. Clinical review for general practice. 2025; 6 (2): 102–108 (In Russ.). DOI: 10.47407/ kr2024.6.2.00576


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

Scopus
doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru